Cloud & SaaS validation · Pharma · Biotech · MedTech

Cloud and SaaS validation — draw the boundary right, keep the release velocity.

One boundary. Two responsibilities. Zero findings.

GxP-compliant cloud validation with a clear vendor-audit boundary, a release-regression framework that holds, and cross-stream programme leadership when IT, quality and business have to deliver at the same time.

100 % audit pass rate 0 critical findings 60+ validated systems 15+ years cloud / SaaS practice
Platforms we validate on
01 Context

What makes cloud validation different.

Setting up cloud validation GxP-compliant is more than a technical update of existing CSV processes. In Pharma, Biotech and MedTech, cloud operation shifts the responsibility boundaries — and with them the validation scope. The shared responsibility model splits three clearly defined layers:

  • IaaS (AWS, Azure, Google Cloud) — responsible for hardware, hypervisor, network.
  • PaaS / SaaS-Plattform (Veeva Vault, MasterControl, Box) — application logic, platform releases, standard configuration.
  • Customer (you) — configuration, data, processes and the GxP compliance of your use case.

Classical on-prem validation doesn't carry over 1:1 to SaaS. Four points make the difference:

01

Audit trail at the vendor

Partially held by the vendor — access and export must be contractually secured.

02

Backup responsibility shifts

What happens during vendor outage? Recovery, retention and replay are non-trivial.

03

Forensic data on demand

Findings investigations need data that isn't automatically available — clauses required.

04

Data residency

Decides EMA + GDPR compliance. EU-region hosting and transfer assessment are mandatory.

Anyone who doesn't address these shifts systematically validates formally — but not audit-secure.

02 Vendor-audit boundary

Set the vendor-audit boundary right.

The most important question in any cloud validation isn't 'how do we validate?' — it's 'what do we need to validate ourselves, and what can the vendor cover?' This is exactly where most projects fail: too little vendor scrutiny, or unnecessarily duplicated evidence.

A
SOC 2 II ISO 27001 ISO 27018 SOC 1

Reading vendor certificates correctly

SOC 2 Type II evidences operational controls over a period. ISO 27001 covers the information-security management system. ISO 27018 adds data-protection for personal data in the cloud. SOC 1 covers finance-relevant controls. These are important building blocks — they do not replace a GxP-specific vendor audit per Annex 11.3. They evidence security maturity, not the fit for validation-mandatory processes.

B Annex 11.3 obligation

Vendor-audit obligation under Annex 11.3

The regulated operator stays responsible — you must formally audit your cloud vendor. Either as a Custom-Audit (your team on-site at the vendor) or via a Pool-Audit such as the Pharmaceutical Cloud Auditing Pool. Pool audits cut effort significantly but don't cover every customer-specific risk.

C
Configuration Customizing

Configuration vs. Customising — the most expensive line

Configuration (workflow steps, fields, roles) is validation-ready in the standard. Customising (custom code, custom objects, API extensions) leaves the vendor's validated standard path and requires your own OQ/IQ/PQ evidence. This is where costs and risks explode.

D
Veeva MasterControl AWS/Azure

Where the boundary runs — practical examples

At Veeva Vault, the line follows the Vault Configuration API. MasterControl separates standard workflows from customer-specific extensions. AWS or Azure custom solutions on IaaS basis are typically completely in customer scope.

Deep-dive · GAMP 5

How GAMP 5 structures the vendor assessment

Risk-based supplier classification, qualification depth per category, and how the vendor-audit obligation maps into the GAMP 5 lifecycle.

See GAMP 5 compliance →
03 Release-regression framework

Stay validated — at vendor speed.

Cloud validation hits a structural paradox: validation demands stability and documented reproducibility — the cloud vendor ships new releases on ever-shorter cycles. Without a framework, every release becomes a fresh introduction, and you lose the validated state between two audits.

Without framework
Tage

Every release ground-up: workshops, impact analysis, new test cases, doc updates. Blocks validation capacity that's missing from your actual project.

With dhc framework
4–8 h

Predefined risk clusters, maintained regression test suite, clear paths for re-validation depth. Same regulatory rigour, fraction of the effort.

Platform release rhythm Q1Q2Q3Q4
Veeva Vault 3 major releases per year
4–8 h / release
MasterControl Continuous hotfix releases
2–4 h / change
Custom SaaS · AWS / Azure Vendor sprint cycles
Per sprint frequency

The framework is a documented process, not a tool. You take it over into self-operation at project end — independent from external support.

04 Hybrid stack

On-prem + cloud — validate together.

In Pharma 2026, no company is 'pure cloud'. Even manufacturers with aggressive cloud strategies still run on-prem systems — production-near MES, established LIMS, older ERP. Validation has to reflect that reality, not ignore it.

On-Prem
MES LIMS ERP
Cloud
Cloud-QMS eDMS RIM

Validation follows the data, not the deployment model

Whether a batch record originates in on-prem MES and flows into cloud QMS — or the other way around — is regulatorily secondary. What matters: does data integrity hold per ALCOA+ across all system boundaries, and is the audit trail end-to-end traceable?

Hand-over points are the silent risk

Every hybrid stack has hand-over points where data can leave the validated path. Typical: a batch record passes MES → middleware → cloud QMS and loses the audit-trail link to the original batch. Invisible in daily ops — visible in the FDA audit.

Cross-system integration tests

The critical interfaces: MES ↔ cloud QMS, LIMS ↔ cloud eDMS, ERP ↔ cloud platform. Each requires documented integration tests with end-to-end data continuity — not isolated module tests.

05 Cross-stream programme lead

Three streams in parallel — one owner for the interface.

Cloud and SaaS projects in Pharma rarely fail on the technology. They fail because Application, Compliance and Business stream deliver in parallel — and nobody bridges the seam between them. That bridge is what we provide.

Application stream
Configuration · Vendor releases · Interfaces

Sandbox + production setup, technical interfaces, vendor release cadence.

Compliance stream
Validation artefacts · Risk · Audit-trail

Risk assessment, audit-trail design, supplier-audit evidence.

Business stream
Process · Training · Adoption

Process design, user training, adoption, change management in the business unit.

Each stream has its own tempo, owners and success criteria. Without overarching steering they run side-by-side — until shortly before go-live, when the gaps surface.

What dhc owns in programme management

  • Master plan with clear phase-gates
  • Cross-stream risk register
  • Synchronous steering cadence
  • Clean escalation paths

Validation management and programme leadership sit in one responsibility — the E-pillar of our IVE methodology.

60+Systems validated
15+Years of practice
100 %Audit-pass
0Findings
06 Bonus material

Cross-stream synergy strategy — the strategy guide.

On 20-odd pages we show how we synchronise Application, Compliance and Business stream in one programme — with concrete examples from cloud-validation projects in Pharma. The guide complements this service page. It includes templates you can apply in your own programme right away — independent of any consulting engagement.

~20 pages PDF · DE Free · email-gated
07 FAQ

Common questions about cloud and SaaS validation.

Vendor Does our cloud vendor's SOC 2 audit cover the supplier-audit obligation?

No. SOC 2 Type II evidences operational security controls — it does not replace a GxP-specific supplier audit per Annex 11.3. You can bring a SOC 2 audit in as a building block, but the regulatory obligation to perform your own supplier assessment stays with the regulated operator.

Release Do we have to fully re-validate at every cloud vendor release?

No. With an established release-regression framework, the effort drops to 4–8 hours per Veeva release or 2–4 hours per MasterControl change. Prerequisite: predefined risk clusters and a maintained regression test suite.

Pricing What does a cloud/SaaS initial validation typically cost?

The effort depends on platform, configuration depth and number of interfaces. An isolated SaaS initial validation (standard configuration, no custom extensions) typically runs six to twelve weeks. Fixed prices are possible once scope is defined.

Sovereignty How do you handle data sovereignty with US-hosted cloud under EMA audit?

Three levers: contractually secured data location in EU regions, documented transfer impact assessment per GDPR, and audit-trail access from EU jurisdiction. For US-only hosting, we check whether standard contractual clauses and supplementary measures suffice for your GxP use case.

Engagement Can we outsource programme leadership to dhc, or do you only consult?

Both. We take over programme responsibility as an interim lead — or support your internal programme leadership in an advisory role. We define the split in the initial analysis.

Let's make your project
audit-proof.

Your project deserves a validation that accelerates go-live — not blocks it. Benefit from the assurance of 60+ successful projects.

60+
Projects
15+
Years
100 %
Audit-Pass
0
Findings
Book a no-strings strategy call

Free initial assessment · Focus on your project, not slides

or
Call directly +49 170 7878065 Mon–Fri 8 a.m. – 5 p.m. Send an email contact@daniel-herrmann.io Reply within 24 h